Hirtle Callaghan & Co LLC
- SEC CIK
- 0001360710
- Latest filing
- Aug 14, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Hirtle Callaghan & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −2,551−100.0% | Sold out | Holders |
| Q4 2024 | 2,551 | $288.5K | <0.1% | +2,551 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −15,866−100.0% | Sold out | Holders |
| Q2 2022 | 15,866 | $1.72M | 0.1% | −4,659−22.7% | Reduced | Holders |
| Q1 2022 | 20,525 | $2.43M | 0.1% | +16,247+379.8% | Added | Holders |
| Q4 2021 | 4,278 | $602.0K | <0.1% | +4,278 | New | Holders |